<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

CU Cancer Center News and Stories

Liver Cancer

Lung Cancer    Liver Cancer    Pancreatic Cancer    Esophageal Cancer    Stomach Cancer

For Many Cancers, 5-Year Survival Rates at CU Cancer Center Exceed National Rates

A key yardstick used to evaluate success in cancer treatment shows that for many cancers, a higher percentage of people diagnosed at the University of Colorado Cancer Center have survived five years or more beyond their diagnoses than for the nation as a whole.

Author Mark Harden | Publish Date June 02, 2024
Full Story

Patient Care    Liver Cancer    Colorectal Cancer   

Colorectal Cancer Patient Doug Scanlon Grateful for Cutting-Edge Care at CU Cancer Center 

For Doug Scanlon, last year’s Walk to End Colon Cancer was a victory lap. This year, it’s more like a homecoming. 

Author Greg Glasgow | Publish Date June 22, 2023
Full Story

Patient Care    Liver Cancer

Surviving a 1-in-5-Million Liver Cancer

The doctors she saw initially didn’t seem too concerned, but 22-year-old Ella Neal knew something was seriously wrong. A persistent, unusual abdominal pain was keeping her up at night and distracting her from her studies at the University of Colorado Boulder.

Author Greg Glasgow | Publish Date August 25, 2021
Full Story

CU Cancer Center In the News

News Medical

Study shows effectiveness of treating pancreatic cancer patients with chemotherapy before surgery

news outletNews Medical
Publish DateJune 19, 2024

A new study led by University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, reveals that nearly 5% of pancreatic adenocarcinoma patients achieved a pathological complete response (pCR) after pre-surgical chemotherapy or chemoradiotherapy. This significant finding indicates that patients with pCR have a 63% five-year survival rate, compared to 30% for those without pCR, suggesting the potential for tailored treatments to improve outcomes.

Full Story
Cancer Network

Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups

news outletCancer Network
Publish DateJune 14, 2024

In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.

Full Story
Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the University of Colorado Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story